Orally inhaled levodopa (CVT-301) for early morning OFF periods in Parkinson's disease

Authors: Hauser, Robert A., Isaacson, Stuart H., Ellenbogen, Aaron, Safirstein, Beth E., Truong, Daniel D., Komjathy, Steven F., Kegler-Ebo, Deena M., Zhao, Ping, Oh, Charles

Source: In Parkinsonism and Related Disorders July 2019 64:175-180

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults

Authors: Scott, Daniel A., Komjathy, Steven F., Hu, Branda T., Baker, Sherryl, Supan, Lois A., Monahan, Carol A., Gruber, William, Siber, George R., Lockhart, Stephen P.

Source: In Vaccine 2007 25(33):6164-6166

This result is not displayed to guests.
Login for full access.

The Potent BACE1 Inhibitor LY2886721 Elicits Robust Central Aβ Pharmacodynamic Responses in Mice, Dogs, and Humans.

Authors: May, Patrick C., Willis, Brian A., Lowe, Stephen L., Dean, Robert A., Monk, Scott A., Cocke, Patrick J., Audia, James E., Boggs, Leonard N., Borders, Anthony R., Brier, Richard A., Calligaro, David O., Day, Theresa A., Ereshefsky, Larry, Erickson, Jon A., Gevorkyan, Hykop, Gonzales, Celedón R., James, Douglas E., Jhee, Stanford S., Komjathy, Steven F., Li, Linglin

Source: Journal of Neuroscience; 1/21/2015, Vol. 35 Issue 3, p1199-1210, 12p

Subject Terms: PROTEASE inhibitors, AMYLOID beta-protein, ALZHEIMER'S disease, CLINICAL trials, NEURODEGENERATION, MEMORY loss, DEMENTIA